Skip to main content
Year archive

MEMPHASYS LIMITED. — 2021 filings

All 47 regulatory filings released by MEMPHASYS LIMITED. (MEM) in 2021, sourced directly from the official regulator.

47 Filings
2021 Period
2021 filings (47)
Filing Released Lang
First Felix System commercial sale for clinical IVF use 3 pages 194.0KB
Capital/Financing Update
2021-12-19 English
Memphasys & Monash IVF commence clinical trial of FELIX 3 pages 191.6KB
Regulatory Filings
2021-12-08 English
SAMSON stallion fertility device used in field trials 2 pages 208.0KB
Regulatory Filings
2021-12-01 English
Change of Director's Interest Notice AC 3 pages 192.3KB
Director's Dealing
2021-11-25 English
Results of Meeting 1 page 53.7KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-24 English
First Sale of FelixTM in Research Application 2 pages 240.0KB
Capital/Financing Update
2021-11-21 English
Verification and Validation Assessments Complete 2 pages 231.0KB
Regulatory Filings
2021-11-02 English
MEM receives $1.36m R&D tax rebate 2 pages 174.3KB
Regulatory Filings
2021-10-24 English
Notification of cessation of securities - MEM 4 pages 24.4KB
Share Issue/Capital Change
2021-10-24 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 352.9KB
Interim / Quarterly Report Q1 2022
2021-10-20 English
Notice of Annual General Meeting/Proxy Form 15 pages 493.5KB
AGM Information
2021-10-18 English
Application for quotation of securities - MEM 6 pages 27.8KB
Share Issue/Capital Change
2021-09-27 English
Cleansing Notice - Section 708A(5)(e) 1 page 215.4K
Regulatory Filings
2021-09-27 English
Acceleration of reproductive biotechnology portfolio 3 pages 251.5KB
Regulatory Filings
2021-09-19 English
Appendix 3G correction 19 pages 438.0KB
Regulatory Filings
2021-09-16 English
Notification regarding unquoted securities - MEM 7 pages 30.8KB
Share Issue/Capital Change
2021-09-13 English
Change of Director's Interest Notice - AC and AG 5 pages 208.8KB
Director's Dealing
2021-09-09 English
Appendix 3G 19 pages 438.1KB
Regulatory Filings
2021-09-02 English
Notification regarding unquoted securities - MEM 7 pages 30.7KB
Share Issue/Capital Change
2021-08-31 English
FY21 Corporate Governance Statement and Appendix 4G 26 pages 538.7KB
Governance Information
2021-08-30 English
Preliminary Final Report 18 pages 926.7KB
Regulatory Filings
2021-08-29 English
FY21 Full Year Statutory Accounts 60 pages 1.2MB
Annual Report FY 2021
2021-08-29 English
Results of General Meeting 2 pages 204.1KB
Declaration of Voting Results & Voting Rights Announcements
2021-08-23 English
General Meeting to be held as a Virtual Meeting of members 2 pages 225.9KB
Proxy Solicitation & Information Statement
2021-08-19 English
Notification regarding unquoted securities - MEM 7 pages 30.8KB
Share Issue/Capital Change
2021-07-29 English
Application for quotation of securities - MEM 6 pages 27.6KB
Share Issue/Capital Change
2021-07-29 English
Disclosure Document - Cleansing Notice 1 page 215.1
Regulatory Filings
2021-07-29 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 309.1KB
Interim / Quarterly Report Q4 2021
2021-07-25 English
Notice of General Meeting/Proxy Form 30 pages 540.2KB
Proxy Solicitation & Information Statement
2021-07-22 English
Global andrology expert, Professor John Aitken, joins MEM 2 pages 249.0KB
Board/Management Information
2021-07-04 English
Upgraded Felix Device verification passed 1 page 11
Regulatory Filings
2021-06-30 English
Memphasys completes $3m capital raise 4 pages 307.8KB
Capital/Financing Update
2021-05-25 English
Proposed issue of Securities - MEM 8 pages 35.8KB
Capital/Financing Update
2021-05-25 English
Trading Halt 2 pages 155.2KB
Regulatory Filings
2021-05-24 English
Prof. John Aitken receives distinguished andrology award 2 pages 189.7KB
Regulatory Filings
2021-05-03 English
Assisted reproductive biotechnology products update 3 pages 282.3KB
Capital/Financing Update
2021-05-03 English
Quarterly Activities Report 2 pages 208.9KB
Interim / Quarterly Report Q3 2021
2021-04-29 English
Quarterly Cashflow Report 6 pages 168.2KB
Interim / Quarterly Report Q3 2021
2021-04-29 English
Granted US patents strengthens IP portfolio 2 pages 186.0KB
Regulatory Filings
2021-04-28 English
Felix device - V&V progress and KOL study update 2 pages 203.5KB
Capital/Financing Update
2021-04-26 English
FELIX device Verification and Validation process update 2 pages 211.2KB
Regulatory Filings
2021-03-29 English
Felix device validation testing delayed 2 pages 185.5KB
Regulatory Filings
2021-03-07 English
Half Yearly Report and Accounts 25 pages 1.5MB
Interim / Quarterly Report H1 2021
2021-02-25 English
Cancellation of Performance Options 1 page 138.0KB
Capital/Financing Update
2021-02-16 English
Change of Director's Interest Notice - Coutts 4 pages 148.8KB
Director's Dealing
2021-02-16 English
Appendix 2A option conversion 15 pages 300.3KB
Share Issue/Capital Change
2021-02-01 English
Disclosure Document - s708A cleansing notice 1 page
Regulatory Filings
2021-02-01 English